POST DOCS

Rolf Bekendam, MD, PhD

3 Blackfan Circle, Room 924
Boston, MA 02115
rbekenda@bidmc.harvard.edu

Rolf is originally from the Netherlands where he received his Medical degree from the University of Groningen. He initially joined as a medical student and was able to continue his research at BIDMC in collaboration with the Aix-Marseille University (France), at which he is currently enrolled in a PhD program. His research has been focused around the development of novel protein disulfide isomerase (PDI) inhibitors using high throughput screening. He is currently conducting research to identify crucial endogenous mediators of PDI inhibition.

Awards:

2015 – Young Investigator Award – International Society on Thrombosis and Haemostasis
2016 – Young Investigator Award – International Society on Thrombosis and Haemostasis

Keiichi Enjoji,PhD

3 Blackfan Circle, Room 924
Boston, MA 02115
kenjoji@bidmc.harvard.edu
 

Keiichi obtained his Ph.D from Kyushu University in Japan in biochemistry. His research is focused on analyzing the role of intrinsic coagulation pathway on stroke using mice model. Previously he worked on the role of cd39/ENTPDase1 in metabolic disease such as atherosclerosis and diabetes and in inflammation at BIDMC.

Sarah Higgins, PhD

3 Blackfan Circle, Room 924
Boston, MA 02115
sjhiggin@bidmc.harvard.edu

Sarah is a postdoctoral research fellow who joined the Flaumenhaft lab to study the critical role of the endothelial angiopoietin-Tie2 pathway in thrombosis, as an extension of the collaborative partnership between the Division of Thrombosis and Hemostasis and Center for Vascular Biology Research at BIDMC. Overall, Sarah’s work aims to apply basic molecular research to tackle unmet global health needs, with a specific focus on vascular biology in the setting of infection, thrombosis and inflammation. Sarah received her B.Sc. in Forensic Science from Trent University and PhD in Laboratory Medicine from the University of Toronto where her work at the Sandra Rotman Centre for Global Health led to a patented host-targeted treatment intervention for cerebral malaria developed in collaboration with industry partners. Outside the lab, Sarah is an avid runner and nature enthusiast who can often be found exploring NE’s many incredible mountains and craft breweries.

Awards:

Frederick Banting and Charles Best Canada Graduate Scholarships CIHR Doctoral Award
2016 – 2018 – American Heart Association Postdoctoral Research Fellowship Founders Affiliate Award

Lin Lin, PhD

Glenn Merrill-Skoloff, B.S.

Glenn is a New England native having been born and raised in Pigeon Cove, Massachusetts. In 1993, he recived a Bachelor of Science degree in Biochemistry fromthe University of Massachusetts at Amherst. He joined the Division of Hemostasis and Thrombosis at New England Medical Center in 1995, migrating to the Beth Israel Deaconess Medical Center when the division relocated in 1999. Since moving to BIDMC, his focus has been studying thrombosis using intravital microscopy anda laser ablation injury model in the cremaster muscle of mice. This technique was developed, in part, by Glenn who is currently the Director of the Intravital Microscopy Core Facility as well as the Laboratory Manager for the division.

Oluwatoyosi Muse, PhD

3 Blackfan Circle, Room 924
Boston, MA 02115
omuse@bidmc.harvard.edu

Oluwatoyosi graduated from Binghamton University with her PhD in Chemistry. Her research is focused on evaluating the effects of protein disulfide inhibitors on platelet function and thrombin generation in clinical samples from patients with solid tumors and myeloproliferative neoplasm.

Christian Peters, PhD

3 Blackfan Circle, Room 924
Boston, MA 02115
cpeters@bidmc.harvard.edu

Christian received his Bachelor of Science at Bethany College in West Virginia.  Afterwards he received his Master’s degree at the Indiana University of Pennsylvania and his PhD in Biomedical Sciences from the University of Toledo.  His research interests have been focused on the cellular and molecular basis of peptide and protein secretion.  He is currently conducting research to demonstrate the movement of distinct populations of alpha-granules in platelets.  Additionally, a portion of his research is focused on endothelial responses to various small molecules.

Anish V. Sharda, MD

3 Blackfan Circle, Room 924
Boston, MA 02115
asharda@bidmc.harvard.edu

Anish V. Sharda, MBBS, is an Instructor of Medicine at Beth Israel Deaconess Medical Center and Harvard Medical School. His current research has focused on understanding the mechanisms of endothelial release of von Willebrand factor and biogenesis of Weibel Palade bodies.

Anish grew up in Central India and arrived to the US after completing his medical school. After obtaining a masters of public health in general epidemiology at the University of Michigan, he moved to even colder climates of Minnesota to pursue residency training in internal medicine in the Twin Cities. Ultimately, a clinical and research fellowship in hematology, hemostasis and thrombosis brought him to Beth Israel Deaconess Medical Center, and in spite of over six years of residence in Boston, Anish prefers Indian cricket over the Red Sox!

Alumni Post-Docs

David A. Barrios, PhD

 

David is a native of Chicago and is an avid fan of both the Cubs and Red Sox. After serving honorably in the U.S. Navy, David went on to receive his B.S. in Chemistry from the University of Illinois at Urbana-Champaign in 2008 and his Ph.D. in Chemistry from North Carolina State in 2013. His current research focuses on lateral flow assay development for screening the efficacy of antiplatelet therapies as well as exploring the role of PDI in hemostasis and thrombosis.

Karen De Ceunynck, PhD

 

Karen is originally from Belgium where she received her Master’s degrees in Biomedical Sciences and Molecular Biotechnology from Ghent University and her PhD in Biochemistry & Biotechnology from the Catholic University of Leuven. Her research has been focused on understanding processes involved in hemostasis and thrombosis and using that knowledge to guide the development of novel therapeutics. She is currently conducting translation research to evaluate how endothelial therapies can reduce uncontrolled blood clotting in the setting of infectious disease. ​

Awards:

2015 – Young Investigator Award – International Society on Thrombosis and Haemostasis
2016 to Present – NIH T32 Training Grant
2016 – Translational Research Training in Hematology (TRTH) – Joint EHA and ASH award
2016 – Abstract Achievement Award – American Society of Hematology (ASH)
2017 – Young Investigator Award – International Society on Thrombosis and Haemostasis

Oskar Eriksson, MD, PhD

Oskar received his MD and PhD from the University of Uppsala in Sweden. His PhD thesis focused on experimental and translational studies on cell signaling by coagulation proteases in the context of cancer. Oskar joined the lab in 2016 and is interested in understanding the role of extracellular thiol isomerases in the initiation of plasma cascade systems during thromboinflammation.

Awards:

2016 to 2018 – International Post Doctoral Fellowship – Swedish Research Council

Jack Stopa, PhD

Jack is originally from Boston where he received his Bachelor of Science in Biochemistry at Denison University, and his PhD in Molecular and Cellular Biology &Biochemistry from Boston University. His research has been focused on understanding the role of protein disulfide isomerase (PDI) in thrombosis, by developing novel ways to search for protein substrates of PDI as well as characterizing new anti-thrombotic therapeutics using PDI as a drug target.  He is currently investigating the interactions between PDI and several of the identified target proteins and their role in thrombosis.

Noppacharn Uaprasert, MD

Noppacharn is originally from Bangkok, Thailand. He received Doctor of Medicine and certified Board of Hematology from Chulalongkorn University. He is a faculty member at Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University. He received a two-year scholarship from Anandamahidol Foundation between 2016-2018 to study in advanced basic science research. His research has been focused on thalassemia and hemoglobinopathies as well as hemostasis and thrombosis. His current research studies are focusing on mechanisms of protein disulfide isomerase in regulation of platelet functions and hemostasis and thrombosis models in mice with hemostatic defects.

Awards:

2017 – Abstract Achievement Award – American Society of Hematology (ASH)